STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few
STAT News · LC · trust 49/100
Exon-skipping drugs present a critical test for the FDA’s goal of encouraging treatments for rare disease.
Read the original at STAT News →
Open in TruthVane →